nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive immunotherapy administered via the hepatic artery and intralesional interleukin-2 in hepatocellular carcinoma
|
Fagan, Elizabeth A. |
|
1989 |
16 |
SA |
p. 151-160 10 p. |
artikel |
2 |
Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study
|
Stoter, G. |
|
1989 |
16 |
SA |
p. 59-63 5 p. |
artikel |
3 |
A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignancies
|
Lindemann, Albrecht |
|
1989 |
16 |
SA |
p. 53-57 5 p. |
artikel |
4 |
A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases
|
Favrot, M. |
|
1989 |
16 |
SA |
p. 129-142 14 p. |
artikel |
5 |
A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma
|
Hamblin, T.J. |
|
1989 |
16 |
SA |
p. 163-167 5 p. |
artikel |
6 |
A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2
|
Wagstaff, J. |
|
1989 |
16 |
SA |
p. 105-109 5 p. |
artikel |
7 |
Clinical immunotherapy studies in the surgery branch of the U.S. National Cancer Institute: brief review
|
Rosenberg, Steven A. |
|
1989 |
16 |
SA |
p. 115-121 7 p. |
artikel |
8 |
Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies
|
West, W.H. |
|
1989 |
16 |
SA |
p. 83-89 7 p. |
artikel |
9 |
Foreword
|
Franks, Christopher R. |
|
1989 |
16 |
SA |
p. 1-2 2 p. |
artikel |
10 |
IL-2: a review of current knowledge
|
Oldham, Robert K. |
|
1989 |
16 |
SA |
p. 5-13 9 p. |
artikel |
11 |
Immune reconstitution after bone-marrow transplantation
|
Symann, M. |
|
1989 |
16 |
SA |
p. 15-19 5 p. |
artikel |
12 |
Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin
|
Paciucci, Paolo Alberto |
|
1989 |
16 |
SA |
p. 67-81 15 p. |
artikel |
13 |
Interlenkin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M. D. Anderson Cancer Center
|
Parkinson, D.R. |
|
1989 |
16 |
SA |
p. 39-48 10 p. |
artikel |
14 |
Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results
|
Thatcher, N. |
|
1989 |
16 |
SA |
p. 161-162 2 p. |
artikel |
15 |
Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients
|
Philip, T. |
|
1989 |
16 |
SA |
p. 91-104 14 p. |
artikel |
16 |
Introduction
|
Pinedo, H.M. |
|
1989 |
16 |
SA |
p. 3- 1 p. |
artikel |
17 |
Lymphokine (IL-2 and TNF-α) mediated cytolytic activity against glioma cells in vitro
|
Herrmann, H.D. |
|
1989 |
16 |
SA |
p. 21-27 7 p. |
artikel |
18 |
Management of a novel immune deficiency with IL-2 therapy
|
Pahwa, R. |
|
1989 |
16 |
SA |
p. 143-149 7 p. |
artikel |
19 |
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study
|
Stoter, G. |
|
1989 |
16 |
SA |
p. 111-113 3 p. |
artikel |
20 |
Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: A phase I/II study
|
Thatcher, N. |
|
1989 |
16 |
SA |
p. 49-52 4 p. |
artikel |
21 |
Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look
|
Benedetti Panici, P. |
|
1989 |
16 |
SA |
p. 123-127 5 p. |
artikel |
22 |
Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma
|
Sznol, Mario |
|
1989 |
16 |
SA |
p. 29-38 10 p. |
artikel |
23 |
Some theoretical and practical limitations of interleukin-2. ten cases of advanced breast cancer treated with continuous infusion of IL-2
|
Israel, L. |
|
1989 |
16 |
SA |
p. 169-171 3 p. |
artikel |
24 |
Summary
|
Pinedo, H.M. |
|
1989 |
16 |
SA |
p. 175-176 2 p. |
artikel |
25 |
The combination of recombinant interleukin-2 and dacarbazine (DTIC) in metastatic malignant melanoma
|
Flaherty, L. |
|
1989 |
16 |
SA |
p. 65-66 2 p. |
artikel |
26 |
The effect of LAK cells and recombinant interleukin-2 in advanced bladder cancer: an experimental and clinical study
|
Steven, K. |
|
1989 |
16 |
SA |
p. 173- 1 p. |
artikel |